Quarterly Transactions Made in Aslan Pharmaceuticals LTD (ASLN)
This table provides information about the institutional ownership of Aslan Pharmaceuticals LTD (ASLN). The information is specifically focused on institutions that hold shares of ASLAN Pharmaceuticals Ltd.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 627,600 | 2,154,730 | 2,782,330 | 1,249,496 | 2,370,288 | 3,619,784 | -837,454 | |
| Q4 2021 | 1,776,685 | 2,307,151 | 4,083,836 | 1,116,010 | 723,950 | 1,839,960 | 2,243,876 | |
| Q1 2022 | 1,936,085 | 104,070 | 2,040,155 | 2,952,643 | 355,258 | 3,307,901 | -1,267,746 | |
| Q2 2022 | 2,843,548 | 379 | 2,843,927 | 732,040 | 4,390,179 | 5,122,219 | -2,278,292 | |
| Q3 2022 | 13,570 | 16,322 | 29,892 | 1,075,790 | 0 | 1,075,790 | -1,045,898 | |
| Q4 2022 | 173,292 | 318,442 | 491,734 | 690,244 | 0 | 690,244 | -198,510 | |
| Q1 2023 | — | 0 | 1,720,561 | 1,720,561 | -1,720,561 | |||
| Q2 2023 | — | 1 | 0 | 1 | -1 | |||
| Q3 2023 | — | 2,272,726 | 0 | 2,272,726 | -2,272,726 | |||
| Q4 2023 | — | — | 0 | |||||
| Q1 2024 | — | — | 0 | |||||
| Q2 2024 | — | — | 0 | |||||
| Q3 2024 | — | — | 0 | |||||